Quote & Headlines
5d 1m 3m 1y 5y 10y
There are no Focus articles on AKBLF.
To learn more about Seeking Alpha PRO, click here.
There are no Related articles on AKBLF.
There are no Transcripts on AKBLF.
There are no News articles on AKBLF.
AKBLF vs. ETF Alternatives
Sunday, Mar 42012, 6:21 AMMerck (MRK) will next year seek FDA approval for a pill for ragweed allergies following a positive Phase III trial. The firm will also apply for authorization of a pill for grass allergies, with both treatments designed to obviate the need for injections. Merck is developing the immunotherapies with Danish drugmaker ALK-Abello (AKBLF.PK). |Sunday, Mar 42012, 6:21 AM| Comment!
We currently have no instablog posts on this stock.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.